Stella Pharma (TSE:4888) Receivables Turnover : 0.00 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Stella Pharma's Revenue for the three months ended in Sep. 2024 was 円0.0 Mil. Stella Pharma's average Accounts Receivable for the three months ended in Sep. 2024 was 円97.4 Mil.

Stella Pharma Receivables Turnover Historical Data

The historical data trend for Stella Pharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma Receivables Turnover Chart

Stella Pharma Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Receivables Turnover

Get a 7-Day Free Trial

3.74

2.78

6.01

3.98

Stella Pharma Quarterly Data
	Mar19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Receivables Turnover	Get a 7-Day Free Trial												0.97	1.09	0.61	1.09	-

Competitive Comparison of Stella Pharma's Receivables Turnover

For the Biotechnology subindustry, Stella Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Pharma's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stella Pharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Stella Pharma's Receivables Turnover falls into.

Stella Pharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Stella Pharma's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

	Receivables Turnover (A: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2024 )	/ (	(Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )
=	269.491	/ (	(59.288	+	76.227)	/	2 )
=	269.491	/	67.7575
=	3.98

Stella Pharma's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

	Receivables Turnover (Q: Sep. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2024 )	/ (	(Accounts Receivable (Q: Mar. 2024 )	+	Accounts Receivable (Q: Sep. 2024 ))	/	count )
=	0	/ (	(76.227	+	118.576)	/	2 )
=	0	/	97.4015
=	N/A

Stella Pharma (TSE:4888) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Stella Pharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Stella Pharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043

Website

https://stella-pharma.co.jp

Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma Headlines

No Headlines